Brokerages Set Glaukos Corporation (GKOS) Price Target at $54.60

Shares of Glaukos Corporation (NYSE:GKOS) have been given a consensus recommendation of “Buy” by the ten analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and eight have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $52.33.

Several equities analysts have recently issued reports on GKOS shares. Zacks Investment Research cut Glaukos Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, May 2nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $54.00 price target on shares of Glaukos Corporation in a research report on Thursday, May 4th. TheStreet cut Glaukos Corporation from a “c” rating to a “d+” rating in a research report on Wednesday, May 3rd. Stephens upgraded Glaukos Corporation from an “equal weight” rating to an “overweight” rating in a research report on Monday, May 8th. Finally, BMO Capital Markets reiterated a “buy” rating and set a $54.00 price target on shares of Glaukos Corporation in a research report on Tuesday, April 11th.

ILLEGAL ACTIVITY NOTICE: “Brokerages Set Glaukos Corporation (GKOS) Price Target at $54.60” was originally published by Transcript Daily and is owned by of Transcript Daily. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://transcriptdaily.com/2017/08/18/brokerages-set-glaukos-corporation-gkos-price-target-at-54-60-updated.html.

Large investors have recently added to or reduced their stakes in the company. State Board of Administration of Florida Retirement System raised its stake in Glaukos Corporation by 1.9% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 7,699 shares of the medical instruments supplier’s stock valued at $264,000 after buying an additional 140 shares in the last quarter. Inspirion Wealth Advisors LLC raised its stake in Glaukos Corporation by 7.4% in the first quarter. Inspirion Wealth Advisors LLC now owns 9,400 shares of the medical instruments supplier’s stock valued at $482,000 after buying an additional 650 shares in the last quarter. American International Group Inc. raised its stake in Glaukos Corporation by 7.1% in the first quarter. American International Group Inc. now owns 10,293 shares of the medical instruments supplier’s stock valued at $528,000 after buying an additional 681 shares in the last quarter. Teachers Advisors LLC raised its stake in Glaukos Corporation by 5.7% in the fourth quarter. Teachers Advisors LLC now owns 27,789 shares of the medical instruments supplier’s stock valued at $953,000 after buying an additional 1,506 shares in the last quarter. Finally, Great West Life Assurance Co. Can bought a new stake in Glaukos Corporation during the first quarter valued at $102,000. 89.63% of the stock is owned by institutional investors and hedge funds.

Glaukos Corporation (GKOS) traded down 0.17% during mid-day trading on Friday, reaching $36.20. The company’s stock had a trading volume of 152,755 shares. The firm’s market capitalization is $1.25 billion. Glaukos Corporation has a 52 week low of $28.26 and a 52 week high of $52.49. The firm’s 50 day moving average price is $41.36 and its 200 day moving average price is $43.37.

Glaukos Corporation Company Profile

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm’s canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream.

Analyst Recommendations for Glaukos Corporation (NYSE:GKOS)

Receive News & Ratings for Glaukos Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glaukos Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply